Therapy Areas: Cardiovascular
12 June 2019 - - German pharmaceutical company Boehringer Ingelheim and US-based Eli Lilly and Company (NYSE: LLY) have released full data from the CAROLINA trial demonstrating that Trajenta ...
12 June 2019 - ZOLL Medical Corporation on Tuesday announced a definitive agreement to acquire Cardiac Science Corporation (CSC), a portfolio company of Aurora Resurgence, a Los Angeles-based private ...
12 June 2019 - Cardiovascular company CorMatrix Cardiovascular Inc revealed on Tuesday that it has received US FDA 510(k) market clearance for the Cor PATCH for epicardial tissue support and repair in...
11 June 2019 - - A pre-specified exploratory analysis of renal data from the Phase III DECLARE-TIMI 58 trial, the broadest cardiovascular outcomes trial of a sodium-glucose co-transporter 2 (SGLT...
11 June 2019 - - US-based molecular biotechnology company ProtoKinetix, Inc. (OTCQB: PKTX) has reached midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used...
10 June 2019 - - US-based biotechnology company Goldfinch Bio, Inc has initiated dosing in a Phase 1 clinical trial evaluating GFB-887, its subtype-selective, small molecule TRPC5 inhibitor, as a pote...